Esther Drent
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 05, 2022
αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression.
Journal: Journal of personalized medicine
Published: March 31, 2021
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.
Journal: International journal of molecular sciences
Published: December 16, 2020
Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2020
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 06, 2018
Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design.
Journal: PloS one
Published: November 17, 2017
A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 21, 2016
γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs.
Journal: Blood
Published: September 29, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026